Semler Scientific, Inc. (SMLR)

Market Cap	512.07M
Revenue (ttm)	58.94M
Net Income (ttm)	15.91M
Shares Out	8.29M
EPS (ttm)	2.04
PE Ratio	30.31
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	548,312
Open	59.50
Previous Close	61.34
Day's Range	58.10 - 65.14
52-Week Range	20.88 - 81.56
Beta	1.18
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 4, 2024

About SMLR

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company’s products serve cardiologists, internists, ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 21, 2014
• Employees: 92
• Stock Exchange: NASDAQ
• Ticker Symbol: SMLR
• Website: https://www.semlerscientific.com

Financial Performance

In 2023, Semler Scientific's revenue was $68.18 million, an increase of 20.28% compared to the previous year's $56.69 million. Earnings were $20.58 million, an increase of 43.69%.